Discard volume necessary for elimination of heparin flush effect on thromboelastography

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 2, 2010, Pages 192-195

  Durila, Miroslav ^a   Kalinčík, Tomáš ^b   Pacáková, Zuzana ^c   Cvachovec, Karel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

Author keywords

Arterial blood sampling; Coagulation; Discard volume; Heparin flush; Kaolin activated; Thromboelastography

Indexed keywords

ENOXAPARIN; HEPARIN; HEPARIN LYASE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; BLOOD VOLUME; CLINICAL ARTICLE; FEMALE; HUMAN; INDWELLING CATHETER; MALE; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

ADULT; AGED; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; THROMBELASTOGRAPHY; YOUNG ADULT;

EID: 76449087564     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283338c0d     Document Type: Article

References (14)

1. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie: einem neuen Untersuchungs verfahren [Studies with thrombelastography coagulation: a new investigation procedure]. Klin Wochenschr 1948; 26:577-583.
2. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90.
3. Abramson DC, Abouleish EI, Pivalizza EG, Luehr SL, Myers T, Phillips MD. Heparinase-guided thrombelastography in an anticoagulated parturient. Br J Anaesth 1996; 77:556-558.
4. Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006; 10:R160.
5. Mahla E, Lang T, Vicenzi MN, Werkgartner G, Maier R, Probst C, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001; 92:572-577.
6. Coppell JA, Thalheimer U, Zambruni A, Triantos CK, Riddell AF, Burroughs AK, et al. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays. Blood Coagul Fibrinolysis 2006; 17:97-104.
7. Schulte A, Clark M. The effect of line flush heparin contamination on thromboelastograph trace analysis. Anaesthesia 2008; 63:1381-1382.
8. Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 2002; 16:545-550.
9. Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth 1997; 78:175-179.
10. McKee RF, Hodson S, Dawes J, Garden OJ, Carter DC. Plasma concentrations of endogenous heparinoids in portal hypertension. Gut 1992; 33:1549-1552.
11. Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37:463-470.
12. Kettner SC, Gonano C, Seebach F, Sitzwohl C, Acimovic S, Stark J, et al. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg 1998; 86:691-695.
13. Zambruni A, Thalheimer U, Coppell J, Riddell A, Mancuso A, Leandro G, et al. Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and noncirrhotic patients. Scand J Gastroenterol 2004; 39:830-836.
14. Zmuda K, Neofotistos D, Ts'ao CH. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol 2000; 113:725-731.